HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -6.7% ·
share flow +30.0% ·
net new positions -7.1%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +5 | 37.66M | $1.37B | +12 | −6 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | — |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | — |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | — | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | — |
| Q2 2024 | 13 | — | 3.50M | $105.70M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.58M | — | $54.40M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.37M | +784.6% | $47.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.37M | +784.6% | $47.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Marshall Wace ✦ | 929.74K | +165.2% | $31.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 929.74K | +165.2% | $31.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 902.93K | +22.8% | $31.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 902.93K | +22.8% | $31.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 568.67K | +15.4% | $19.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 500.00K | +66.7% | $17.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 480.61K | +35.0% | $16.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 480.61K | +35.0% | $16.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 468.41K | +16.1% | $16.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 296.62K | -6.6% | $10.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 275.59K | +92.7% | $9.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 158.86K | +11.4% | $5.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 50.50K | -24.3% | $1.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 19.79K | +33.0% | $681,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 6.33K | -91.1% | $217,919 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Wellington Management | $625,680 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 306 holders, 54.70M shares, $1.38B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.